Overexpressed IL32 led favorable prognosis in BC; thereby, we suppose the overexpression of IL32 with m6A modification would boost the recruitment of CD4 + T cells and Dendritic cells, to play the role of antitumor. This evidence concerns the gene IL32 and breast cancer.